Royal Bank of Canada’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-50,000
| Closed | -$9K | – | 7727 |
|
|
2024
Q1 | $9K | Buy |
+50,000
| New | +$24.4K | ﹤0.01% | 6261 |
|
|
2023
Q3 | – | Sell |
-1
| Closed | – | – | 7776 |
|
|
2023
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7795 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 7627 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 7894 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 8016 |
|
|
2022
Q2 | $0 | Buy |
+1
| New | +$549 | ﹤0.01% | 7853 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7354 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7026 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6989 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 7123 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7206 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7238 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7277 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6698 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7220 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7020 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6837 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6900 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6982 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6642 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6305 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6370 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6426 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6043 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6080 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6718 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6863 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6824 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6760 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 5806 |
|
|
2013
Q4 | – | Hold |
0
| – | -$2K | – | 6200 |
|
|
2013
Q3 | – | Sell |
-2
| Closed | -$64.4K | – | 5876 |
|
|
2013
Q2 | $87K | Buy |
+2
| New | +$112K | ﹤0.01% | 4384 |
|
Other funds holding BIOL
Royal Bank of Canada's BIOL Position: Q2 2024 in Review
Royal Bank of Canada sold out of Biolase, Inc. (BIOL) in Q2 2024, closing a stake of 50,000 shares — an estimated $9K sold.
Royal Bank of Canada first reported a position in BIOL in Q2 2013 and held it in 7 quarters. The position peaked at $87K in Q2 2013. 2 funds tracked by Wall St. Rank hold BIOL as of Q2 2024.
- Royal Bank of Canada reported no remaining Biolase, Inc. position as of Q2 2024 after selling out during the quarter.
- Royal Bank of Canada sold 50,000 Biolase, Inc. shares in Q2 2024, an estimated $9K.
- Royal Bank of Canada first reported a position in Biolase, Inc. in Q2 2013 and held it in 7 quarters.
- Royal Bank of Canada's Biolase, Inc. position peaked at $87K in Q2 2013.
- 2 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2024.
Based on Royal Bank of Canada's 13F filing for Q2 2024, filed 14 Aug 2024.